UnitedHealth Group (NYSE: UNH) recently reported its Q3 results, with revenues and earnings exceeding our expectations.

I discuss and analyze UNH's cautious FY2025 guidance, attributing lower bottom-line to various factors. Click here to read my ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about ...

UnitedHealth earnings topped forecasts, but the Dow Jones member lowered the top end of its full-year outlook.

Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on UnitedHealth (UNH – Research Report) today and set a price target of ...

Shares of UnitedHealth Group tumbled Tuesday as the company lowered its full-year outlook to reflect the impact of a February ...

UNH, CI, HUM and MOH are likely to navigate industry ... that the majority of the unknowns have been cleared up, views the stock selloff as overdone, and would use it as an opportunity to buy ...

The UNH stock performance is affected by management’s full-year 2024 outlook of $15.50 to $15.75 per share in net income, ...

We recently compiled a list of the Jim Cramer is Talking About These 14 Stocks Before Earnings. In this article, we are going ...

Quarterly profit of $6.06 billion at the Minnetonka-based company beat analyst estimates on a per-share basis as revenue grew ...

Elevance is a high-quality stock with consistent EPS growth, trading at a significant discount to peers like UnitedHealth.